200 related articles for article (PubMed ID: 30740857)
21. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
22. Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain.
Herczenik E; van Haren SD; Wroblewska A; Kaijen P; van den Biggelaar M; Meijer AB; Martinez-Pomares L; ten Brinke A; Voorberg J
J Allergy Clin Immunol; 2012 Feb; 129(2):501-9, 509.e1-5. PubMed ID: 21962992
[TBL] [Abstract][Full Text] [Related]
23. Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies.
van den Biggelaar M; Bierings R; Storm G; Voorberg J; Mertens K
J Thromb Haemost; 2007 Nov; 5(11):2235-42. PubMed ID: 17958741
[TBL] [Abstract][Full Text] [Related]
24. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
Swystun LL; Ogiwara K; Rawley O; Brown C; Georgescu I; Hopman W; Labarque V; Male C; Thom K; Blanchette VS; Carcao MD; Lillicrap D
Blood; 2019 Sep; 134(11):880-891. PubMed ID: 31350267
[TBL] [Abstract][Full Text] [Related]
25. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.
Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A
Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210
[TBL] [Abstract][Full Text] [Related]
27. The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
Shi Q; Schroeder JA; Kuether EL; Montgomery RR
J Thromb Haemost; 2015 Jul; 13(7):1301-9. PubMed ID: 25955153
[TBL] [Abstract][Full Text] [Related]
28. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
Jacquemin M
Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
[TBL] [Abstract][Full Text] [Related]
29. Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.
Bouwens EA; Mourik MJ; van den Biggelaar M; Eikenboom JC; Voorberg J; Valentijn KM; Mertens K
Blood; 2011 Nov; 118(22):5947-56. PubMed ID: 21940821
[TBL] [Abstract][Full Text] [Related]
30. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism.
Saenko EL; Yakhyaev AV; Mikhailenko I; Strickland DK; Sarafanov AG
J Biol Chem; 1999 Dec; 274(53):37685-92. PubMed ID: 10608826
[TBL] [Abstract][Full Text] [Related]
31. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models.
Denis CV; Kwack K; Saffaripour S; Maganti S; André P; Schaub RG; Wagner DD
Blood; 2001 Jan; 97(2):465-72. PubMed ID: 11154224
[TBL] [Abstract][Full Text] [Related]
33. Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo.
Shi Q; Kuether EL; Schroeder JA; Perry CL; Fahs SA; Cox Gill J; Montgomery RR
J Thromb Haemost; 2012 Nov; 10(11):2328-37. PubMed ID: 22908929
[TBL] [Abstract][Full Text] [Related]
34. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
Jones TR; Kao KJ; Pizzo SV; Bigner DD
Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.
Chauhan AK; Kisucka J; Lamb CB; Bergmeier W; Wagner DD
Blood; 2007 Mar; 109(6):2424-9. PubMed ID: 17119108
[TBL] [Abstract][Full Text] [Related]
36. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.
Kroner PA; Friedman KD; Fahs SA; Scott JP; Montgomery RR
J Biol Chem; 1991 Oct; 266(29):19146-9. PubMed ID: 1918030
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
38. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice.
Schwarz HP; Lenting PJ; Binder B; Mihaly J; Denis C; Dorner F; Turecek PL
Blood; 2000 Mar; 95(5):1703-8. PubMed ID: 10688827
[TBL] [Abstract][Full Text] [Related]
39. Lectin activity of the coagulation factor VIII/von Willebrand complex.
Santizo F; Zenteno E; Pina-Canseco S; Hernandez-Cruz P; Cruz MM; Mayoral LP; Pérez-Campos E; Martínez-Cruz R
Tohoku J Exp Med; 2009 Mar; 217(3):209-15. PubMed ID: 19282656
[TBL] [Abstract][Full Text] [Related]
40. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain.
Hamer RJ; Koedam JA; Beeser-Visser NH; Bertina RM; Van Mourik JA; Sixma JJ
Eur J Biochem; 1987 Jul; 166(1):37-43. PubMed ID: 3109914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
